Indeed, the best characterized high-affinity GPR84 antagonist, GLPG1205, has been, and is being, assessed clinically in both ulcerative colitis and idiopathic pulmonary fibrosis (8). The gene discussed is GPR84; the disease is pulmonary fibrosis.